Skip to content
The Kids Research Institute Australia logo

The impact of a vancomycin intervention on vancomycin-associated nephrotoxicity in children: a quality improvement initiative

Vancomycin is first-line treatment for methicillin-resistant Staphylococcus aureus infections. However, despite guideline recommendations, there is no evidence that targeting vancomycin trough concentrations of ≥15 mg/L in children confers clinical benefit and is associated with vancomycin-associated nephrotoxicity. 

Citation:
Nettleton MR, Shim HEM, Abbotsford J, …….. Snelling T, Yeoh DK, Bowen AC, Blyth CC, Campbell AJ. The impact of a vancomycin intervention on vancomycin-associated 

Abstract:
Vancomycin is first-line treatment for methicillin-resistant Staphylococcus aureus infections. However, despite guideline recommendations, there is no evidence that targeting vancomycin trough concentrations of ≥15 mg/L in children confers clinical benefit and is associated with vancomycin-associated nephrotoxicity.